Donald McCarthy
Director/Board Member at Abcuro, Inc.
Profile
Dr. Donald McCarthy holds a PhD in Immunology and Biochemistry from the State University of New York in Albany.
He did his postdoctoral fellowship at the Cardiovascular Research Institute at UCSF.
Following his fellowship, Donnie co-founded Empire Biotechnologies, a GI therapeutics company, and AMP Biotech Research, a research group providing diligence to public investors.
He was also a Senior Fellow in Entrepreneurship at Life Science Angels where he helped source and evaluate new deals.
He was a Managing Director at Panorama Research, where he oversaw the strategy and development of several wholly owned subsidiaries.
In addition, he was an Advisor to KCK Group, where he provided diligence for potential investments in therapeutics companies.
Most recently Donnie was a Partner at Global Founders Capital where he founded, and invested in, multiple therapeutics companies.
Donald McCarthy active positions
| Companies | Position | Start |
|---|---|---|
Abcuro, Inc.
 Abcuro, Inc. Miscellaneous Commercial ServicesCommercial Services Abcuro, Inc. develops bio-therapeutics for the treatment of autoimmunity and cancer. the company was founded in 2015 and is headquartered in Newton, MA. | Director/Board Member | 2022-08-31 |
Former positions of Donald McCarthy
| Companies | Position | End |
|---|---|---|
| Pyrogenyx, Inc. | Director/Board Member | 2023-06-30 |
| Global Founders Capital/Us/ | Private Equity Investor | 2022-05-31 |
Empire Biotechnologies, Inc.
 Empire Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Empire Biotechnologies, Inc. engages in the development of an orally delivered, therapeutic protein capable of significantly increasing the absorption of nutrients in the intestine. It focuses on treating malabsorption resulting from diseases and syndromes including short bowel syndrome, nectotizing enterocolotis, cystic fibrosis, wasting syndrome, and infant prematurity. The company was founded by Donald McCarthy and Piero Mendez and is headquartered in San Franciso, CA. | Chief Executive Officer | 2019-11-30 |
| Amp Bioresearch LLC | Consultant / Advisor | 2018-03-31 |
Samsara Biocapital LLC
 Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Private Equity Investor | - |
Training of Donald McCarthy
| University of Augsburg | Undergraduate Degree |
| Albany Medical College | Graduate Degree |
| The College of Nanoscale Science & Engineering | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Empire Biotechnologies, Inc.
Empire Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Empire Biotechnologies, Inc. engages in the development of an orally delivered, therapeutic protein capable of significantly increasing the absorption of nutrients in the intestine. It focuses on treating malabsorption resulting from diseases and syndromes including short bowel syndrome, nectotizing enterocolotis, cystic fibrosis, wasting syndrome, and infant prematurity. The company was founded by Donald McCarthy and Piero Mendez and is headquartered in San Franciso, CA. | Commercial Services |
Abcuro, Inc.
Abcuro, Inc. Miscellaneous Commercial ServicesCommercial Services Abcuro, Inc. develops bio-therapeutics for the treatment of autoimmunity and cancer. the company was founded in 2015 and is headquartered in Newton, MA. | Commercial Services |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Finance |
| Pyrogenyx, Inc. | |
| Global Founders Capital/Us/ | Finance |
| Amp Bioresearch LLC |
- Stock Market
- Insiders
- Donald McCarthy
